Clearbridge Health

Broker's Calls

949 Broker's Digest


Haidilao International

Price target:

UOB Kay Hian “buy” HK$52.10

Broker's Calls

Clear skies for ClearBridge Health as PhillipCapital expects stronger recovery in 2H20

PhillipCapital has maintained its “buy” rating and target price of 26 cents on ClearBridge Health (CBH) on the back of a stronger 2H20 for the company. 

Company in the news

Clearbridge Health's Indonesian subsidiary sued by JV partner

SINGAPORE (May 31): Clearbridge Health said its indirectly-held subsidiary in Indonesia has been sued by a joint venture partner in Jakarta,


Regulators keep watch as companies jump on Covid-19 bandwagon

SINGAPORE (Apr 30): At the beginning of the Covid-19 outbreak back in January, listed glove-makers experienced a surge in their share price as investors scurried to scoop up these counters.


Singapore firm Biolidics to launch rapid test kit to detect Covid-19 within 10 minutes

SINGAPORE (Mar 30): Singapore-based medical technology firm Biolidics announced Monday it is launching a rapid test kit for Covid-19 that can detect the coronavirus within 10 minutes, with a claime

Broker's Calls

This loss-making healthcare group could be a 'potential unicorn' and treble in value, says Tayrona

SINGAPORE (Feb 5): Emerging areas of precision medicine could transform loss-making healthcare group Clearbridge Health into a “potential unicorn in the making”, according to Tayrona Financial, the


Healthcare stocks get a shot in the arm as Wuhan virus fears rise

SINGAPORE (Jan 21): The outbreak of a new SARS-like virus originating in Wuhan, the capital of China’s Hubei province, is putting Asian stock markets on edge.

Equity raising

Clearbridge Health in private placement to raise $11.3 mil to speed up Asia growth plans

SINGAPORE (July 29): Clearbridge Health is raising $11.34 million from a share placement exercise to accelerate its growth plans in Asia’s healthcare market.


Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil

SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.


Clearbridge subsidiary to issue $2 mil in convertible bonds

SINGAPORE (Mar 25): Clearbridge Health Limited’s subsidiary, Clearbridge Biophotonics, is set to issue $2 million in convertible bonds to develop its proprietary computational imaging microscopy te

Be informed of the stories that matter